PDF

Treating Adrenal Insufficiency and Hypotension with Glycyrrhiza

Abstract

Glycyrrhiza may be appropriate as an adjunctive therapy for a variety of disorders involving mild adrenal insufficiency, low aldosterone output, or hyperkalemia due to effects on 11-β-HSD enzymes, direct effects at mineralocorticoid receptors, and downstream effects on aldosterone as well as fluid and electrolyte balance. Glycyrrhiza has also been shown to help correct hyperkalemia that may result from spirolactone therapy in PCOS. Patients with orthostatic hypotension may respond to Glycyrrhiza therapy due to its ability to improve blood volume and potassium levels and reduce activation of baroreceptors.

>> Hear Dr. Jillian Stansbury Speak at the Restorative Medicine Conference! <<

AARM REFERENCE REVIEWS:

These are AARM reference reviews in which clinicians can obtain a quick overview of understanding with respect to how herbs, nutrients, and hormones can be used effectively in clinical practice. The dosages recommended are based on therapeutic results. Side effects that have not been seen in clinical experience or found in clinical studies but only been theorized have been identified and depicted as Unsubstantiated Theoretical Concerns.

Since many nutrients and herbs on the market have not gone through double-blind studies but have been used extensively in clinical settings for hundreds, and for some thousands of years, these reference reviews have attempted to give a unified opinion on how to use these herbs effectively. The opinions expressed are from different professors and experts in the field of nutritional and botanical medicine. Some information is based on personal opinions and can not be quantified as fact. However, if clinicians only restricted themselves to what is fully proven by double-blind studies, the art of healing and restoring health with nutrients and herbs would be lost.

CLINICAL IMPLICATIONS

Licorice (Glycyrrhiza glabra) can be used to treat certain low blood pressure conditions. Because it can correct low potassium levels via effects on adrenal enzyme systems and support healthy adrenal function and aldosterone metabolism, Glycyrrhiza is primarily used to treat orthostatic hypotension.

KEY HERBS DISCUSSED:

Licorice (Glycyrrhiza glabra)

PRIMARY INDICATIONS:

Hypotention, orthostatic hypotension, hypokalemia

ADJUNCTIVE OR STAND-ALONE TREATMENT:

Adjunctive or Stand-Alone

DOSE OF BIOACTIVE CONSTITUENTS:

The recommended dose of a Licorice standardized extract (containing 20% glycyrrhizic acid) is 250 to 300 mg three times a day.

SYNERGISTIC HERBAL FORMULA:

Licorice (Glycyrrhiza), Eleuthero (Eleutherococcus), Sarsparilla (Smilax), Holy Basil (Tulsi), Rhodiola (Rhodiola), Hawthorne (Crataegus), Alfalfa(Alflalfa)

SIDE EFFECTS (AND CAUTIONS):

When used inappropriately at high doses, Licorice may rarely promote the following complications: hypertension, mineralocorticoid excess, pseudohyperaldosteronism, sodium and water retention, increased urinary potassium loss, hypokalemia, and alkalosis. In patients receiving concomitant cardiac glycosides or diuretics, licorice may potentiate cardiac glycosides (digoxin), and may counteract the effects of diuretics. In patients with hypotension, it is advised to monitor blood pressure and maintain the patient at the lowest dose necessary.

UNSUBSTANTIATED THEORETICAL SIDE EFFECTS:

There is some theoretical evidence as to whether licorice should be administered to patients with liver, kidney, and/or cardiovascular disease. No clinical or scientific study has confirmed this. Most scientific studies published about licorice is that it is a hepatoprotectant.

EDITORS NOTE:

Licorice is clinically considered an effective treatment against liver disease and hepatitis. Intravenous Glycyrrhizic Acid is an anti viral that can be used to treat viral hepatitis.

DISCUSSION

Glycyrrhiza glabra and Glycyrrhiza uralensis (both known as licorice) are among the most versatile, popular, and widely used of all medicinal plants. Glycyrrhiza glabra, in the Fabaceae family, was named ‘sweet root’ by Dioscorides (a Greek physician), and it was widely used in Europe during the Middle Ages and Renaissance. The pleasant, sweet taste is due to the saponic glycoside, glycyrrhizin. Glycyrrhiza is known to impact hormonal balance and the HPA axis. Considered a possible anti-inflammatory, demulcent, and muco-protective agent, Glycyrrhiza has recently been studied for its effect on ACTH feedback loops, corticoids, and androgen steroid metabolism.

Although licorice contains sucrose and glucose, glycyrrhizin is sixty times sweeter than these sugars and gives licorice its characteristic sweet flavor. Glycyrrhizin has become synonymous with glycyrrhizic acid, and researchers often use these terms interchangeably. Glycyrrhizin is composed of the sugar glucuronic acid, and a non-sugar saponin, glycyrrhetic acid. The concentration of glycyrrhizin is variable, from 1-24% of the dried root. Glycyrrhizin is considered responsible for many of the actions of licorice, including its anti-inflammatory and hormonal effects.

BACKGROUND OF RELATED PHYSIOLOGIC EFFECTS AND PROCESSES

Renin, Angiotensin, and Aldosterone’s Effect on Blood Pressure:

Renin is released from renal juxtaglomerular cells in response to low blood volume. In turn, this will ultimately result in the retention of water and increased blood volume, and result in increased blood pressure. A cascade of events occurs when renin is released, causing fluid retention. The first event occurring in this cascade is stimulation of angiotensin production and release. Angiotensin causes blood vessels to constrict by its direct effects on peripheral vascular smooth muscle, which in emergency situations would enhance perfusion, even in cases of very low blood volume. Angiotensin causes aldosterone to be released from zona glomerulosa cells in the adrenal cortex. Aldosterone acts on the distal tubules and collecting ducts in the kidneys to promoting resorption of sodium and water back into the blood stream. Potassium must be excreted to enable water retention. Aldosterone also has central nervous system effects, stimulating the release of ADH (anti-diuretic hormone) from the posterior pituitary. ADH acts on the renal system to help conserve water.

Specific Aldosterone Regulation Mechanisms:

Aldosterone is a mineralocorticoid adrenal steroid that regulates fluid and electrolyte balance by manipulation of electrolytes to help control fluid dynamics in the body. Aldosterone creates osmotic gradients necessary for the kidneys to excrete wastes and yet retain water. Aldosterone does so by enabling the kidneys to spend or excrete important minerals (i.e., potassium) and create the pressure gradients that allow water to be retained. Aldosterone also supports salivary glands, sweat glands, and intestinal mucosal cells, to concentrate fluids despite challenges of osmotic concentration gradients between intracellular and extracellular fluids. Drugs (e.g., spironolactone) that interfere with aldosterone release, treat hypertension due to its effects on electrolyte and blood fluid volume, and thereby causing fluid loss. In addition to renin, adrenocorticotropic hormone (ACTH) promotes aldosterone secretion. Therefore, patients with ACTH abnormalities may experience excess or insufficient activation of aldosterone and also related abnormalities and electrolyte imbalances (particularly hypo- or hyperkalemia). Hence, potassium is also a specific modulator of aldosterone release. When potassium is low, renin release (and the subsequent cascade release of aldosterone) is inhibited in an effort to conserve potassium, even if sodium is high

jrm-2012-2012011_fig1

Glycyrrhiza species of the Leguminosea family

© Steven Foster Group, Inc. All rights reserved.

THE MEDICINAL USES OF GLYCYRRHIZA

Glycyrrhiza for Orthostatic Hypotension:

A sudden change of blood pressure detected by baroreceptors (due to such factors as standing up very quickly) may cause a sequence of physiological actions in order to increase blood flow to the brain, resulting in dizziness and even fainting. High doses of glycerrhizic acid can increase blood pressure to normal when hypotension is due to mild adrenal insufficiency, and patients with orthostatic hypotension may benefit from Glycyrrhiza supplementation as part of their treatment regimen. Additionally, licorice increases water retention and blood volume, which improves cerebral blood flow during rapid fluctuations in systemic blood pressure.

Renin, Angiotensin, and Aldosterone’s Effect on Blood Pressure:

Renin is released from renal juxtaglomerular cells in response to low blood volume. In turn, this will ultimately result in the retention of water and increase blood volume, and then increased blood pressure. A cascade of events occurs when renin is released, causing fluid retention. The first event occurring in this cascade is stimulation of angiotensin production and release. Angiotensin causes blood vessels to constrict, by its direct effects on peripheral vascular smooth muscle, which in emergency situations would enhance perfusion even in cases of very low blood volume. Angiotensin causes aldosterone to be released from zonaglomerulosa cells in the adrenal cortex. Aldosterone acts on the distal tubules and collecting ducts in the kidneys to resorb sodium and water and put it back into the blood stream. Potassium must be excreted for this water to be retained. Aldosterone also has central nervous system effects, stimulating the release of ADH (anti-diuretic hormone) from the posterior pituitary. ADH acts on the renal system to help conserve water.

Specific Aldosterone Regulation Mechanisms:

Aldosterone is a mineralocorticoid adrenal steroid that regulates fluid and electrolyte balance by manipulation of electrolytes to help control fluid dynamics in the body. Aldosterone creates osmotic gradients necessary for the kidneys to excrete wastes and yet retain water. Aldosterone does so by enabling the kidneys to spend or excrete important minerals (such as potassium) and create the pressure gradients that allow water to be retained. Aldosterone also supports salivary and sweat glands, and intestinal mucosal cells, to concentrate fluids despite challenges of osmotic concentration gradients between intracellular and extracellular fluids. Drugs (such as spironolactone) that interfere with aldosterone release, treat hypertension due to its effects on electrolyte and blood fluid volume, thereby causing fluid loss In addition to renin, ACTH (adrenocorticotropic hormone) promotes aldosterone secretion. Therefore, patients with ACTH abnormalities may experience excess or insufficient activation of aldosterone and also related abnormalities and electrolyte imbalances (particularly hypo- or hyperkalemia). Hence, potassium is also a specific modulator of aldosterone release. When potassium is low, renin release (and the subsequent cascade release of aldosterone) are inhibited in an effort to conserve potassium, even if sodium is high.

Glycyrrhiza for Adrenal Insufficiency:

Researchers have demonstrated the ability of licorice to treat adrenal insufficiency as well as stress intolerance via enhancement of the adrenal cortisol response. Glycyrrhiza inhibits 11beta-hydroxysteroid dehydrogenase, the enzyme responsible for inactivating cortisol, and as a result, may elevate abnormally low cortisol levels. Glycyrrhizin and glycyrrhizic and glycyrrhetinic acids have each been shown to inhibit the 11-β-HSD enzymes, thereby allowing cortisol to bind mineralocorticoid receptors. These compounds can also have direct ligand effects on mineralocorticoid and glucocorticoid receptors.

Through its effects on11-β-HSD-1, Glycyrrhiza increases activity at mineralocorticoid receptors, and promote potassium excretion and sodium and water retention. This may be therapeutic in cases of hyperkalemia and hypoaldosteronism.Glycyrrhiza may also benefit women with PCOS and diminish the side effects of spironolactone use.

 

It has been noted that Glycyrrhiza can promote excessive fluid and sodium retention, leading to hypokalemic hypertension in some cases. In a genetic deficiency of the 11-β-HSD enzymes, individuals with preexisting over-stimulation of the mineralocorticoid receptors may be aggravated byGlycyrrhiza. Many cases of individuals who have extreme reactivity to licorice have proven to be those persons with 11-β-HSD deficiency. Likewise, genetic 11-β-HSD abnormalities are increasingly recognized as contributing to some cases of hypertension.

Animal studies have also shown Glycyrrhiza to decrease elevated serum cortisol, ACTH, and potassium, while increasing renin, aldosterone, and sodium concentrations. These effects suggest direct activity on the adrenal-renal-pituitary axis. This aldosterone-like action may cause fluid retention and elevation of blood pressure in some sensitive individuals, but improve symptoms of mineralocorticoid insufficiency. Due to its aldosterone-like effects, Glycyrrhiza is also appropriate for those patients with adrenal insufficiency and related hypotension.

Red Ginseng (Panax ginseng) is an excellent constituent of the synergistic herbal formula for conditions of adrenal hypofunction.

Glycyrrhiza for Hyperkalemia:

Dialysis patients are particularly at risk of electrolyte imbalances (i.e., hyperkalemia), and hyperkalemia can cause life-threatening arrhythmias. Glycyrrhiza may be appropriate for dialysis recipients experiencing hyperkalemia by assisting the body to excrete potassium.

Women with PCOS, prescribed spironolactone to help combat hirsutism, may likewise develop hyperkalemia as an unwanted side effect. The concomitant use of Glycyrrhiza with spironolactone can help to prevent this side effect of hyperkalemia. In a clinical trial, the addition of Glycyrrhizasignificantly reduced the activation of the renin-aldosterone system in patients using spironolactone. Furthermore, the group receiving the additional Glycyrrhiza experienced less metrorrhagia.

DISCLOSURE OF INTERESTS

Dr. Saunders reports personal fees related to employment or seeing patients from CCNM, the Dundas Naturopathic Centre, and from Beaumont Health Systems, Troy Hospital, MI, outside the submitted work. Dr. Winston reports personal fees from Herbalist & Alchemist, Inc, outside the submitted work. Dr. Stansbury and Dr. Zampieron have nothing to disclose.

REFERENCES

  1. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol 2006; 46(3):167–92.
  2. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; 2(8563):821–4.
  3. Morris DJ, Latif SA, Hardy MP, Brem AS. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol. J Steroid Biochem Mol Biol 2007; 104(3-5):161–8.
  4. Ulmann A, Menard J, Corvol P. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors. Endocrinology 1975; 97(1):46–51.
  5. Murakami T, Uchikawa T. Effect of glycyrrhizine on hyperkalemia due to hyporeninemic hypoaldosteronism in diabetes mellitus. Life Sci 1993; 53(5):L63–L68.
  6. Armanini D, Castello R, Scaroni C et al. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 2007; 131(1):61–7.
  7. Inada M. [A 87-year-old woman with mineralocorticoid excess due to 11 beta-HSD2 deficiency]. Nippon Ronen Igakkai Zasshi 2007; 44(4):513–6.
  8. Hammer F, Stewart PM. Cortisol metabolism in hypertension. Best Pract Res Clin Endocrinol Metab 2006; 20(3):337–53.
  9. Al-Qarawi AA, Abdel-Rahman HA, Ali BH, El Mougy SA. Liquorice (Glycyrrhiza glabra) and the adrenal-kidney-pituitary axis in rats. Food Chem Toxicol 2002; 40(10):1525–7.
  10. Epstein MT, Espiner EA, Donald RA, Hughes H. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J 1977; 1(6059):488–90.
  11. Ferrari P. Licorice: a sweet alternative to prevent hyperkalemia in dialysis patients? Kidney Int 2009; 76(8):811–2.

DOI: http://dx.doi.org/10.14200/jrm.2012.1.1011